QSAM Biosciences Inc. (QSAM): Fusion Pharmaceuticals, another radiopha...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Re: Wrangler1 post# 791

Thursday, 09/16/2021 9:20:57 AM

Thursday, September 16, 2021 9:20:57 AM

Fusion Pharmaceuticals, another radiopharmaceutical company in FDA Phase 1, has a market cap of $396.6 million.

Keep Last Read

Next 10 Prev Next

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 02/20/2024 10:19:46 PM
Form 5 - Annual statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 09:51:43 PM
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/20/2024 11:09:38 AM
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/16/2024 02:51:13 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2024 09:00:23 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/08/2024 02:56:06 AM
Form 8-K - Current report • Edgar (US Regulatory) • 01/16/2024 10:08:01 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 01:43:09 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/29/2023 08:51:16 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/16/2023 08:00:24 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:30:59 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/29/2023 10:14:22 AM

InvestorsHub NewsWire

Only $200 per official company press release!